A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

NCT06487702 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: fruquintinib++Candonilimab+ Tegafur，Gimeracil and Oteracil Potassium

Sponsor

Rui-hua Xu, MD, PhD